25 XP   0   0   10

Hainan Honz Pharmaceutical Co
Buy, Hold or Sell?

Let's analyse Honz together

PenkeI guess you are interested in Hainan Honz Pharmaceutical Co. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hainan Honz Pharmaceutical Co. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hainan Honz Pharmaceutical Co

I send you an email if I find something interesting about Hainan Honz Pharmaceutical Co.

Quick analysis of Honz (30 sec.)










What can you expect buying and holding a share of Honz? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.01
Expected worth in 1 year
¥1.25
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
¥-1.53
Return On Investment
-34.5%

For what price can you sell your share?

Current Price per Share
¥4.42
Expected price per share
¥3.75 - ¥5.27
How sure are you?
50%

1. Valuation of Honz (5 min.)




Live pricePrice per Share (EOD)

¥4.42

Intrinsic Value Per Share

¥-3.56 - ¥0.93

Total Value Per Share

¥-0.55 - ¥3.94

2. Growth of Honz (5 min.)




Is Honz growing?

Current yearPrevious yearGrowGrow %
How rich?$187.3m$214.7m-$27.3m-14.6%

How much money is Honz making?

Current yearPrevious yearGrowGrow %
Making money-$25.9m$1.5m-$27.4m-105.9%
Net Profit Margin-35.0%1.3%--

How much money comes from the company's main activities?

3. Financial Health of Honz (5 min.)




What can you expect buying and holding a share of Honz? (5 min.)

Welcome investor! Honz's management wants to use your money to grow the business. In return you get a share of Honz.

What can you expect buying and holding a share of Honz?

First you should know what it really means to hold a share of Honz. And how you can make/lose money.

Speculation

The Price per Share of Honz is ¥4.42. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Honz.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Honz, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.01. Based on the TTM, the Book Value Change Per Share is ¥-0.44 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Honz.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.06-1.3%-0.06-1.3%0.000.1%-0.01-0.3%0.000.0%
Usd Book Value Change Per Share-0.06-1.4%-0.06-1.4%-0.01-0.3%-0.03-0.8%-0.02-0.4%
Usd Dividend Per Share0.010.2%0.010.2%0.010.3%0.010.2%0.010.2%
Usd Total Gains Per Share-0.05-1.2%-0.05-1.2%0.00-0.1%-0.02-0.5%-0.01-0.1%
Usd Price Per Share0.86-0.86-1.20-0.88-1.25-
Price to Earnings Ratio-14.92--14.92-355.49-144.78-149.05-
Price-to-Total Gains Ratio-16.31--16.31--525.82--70.54--74.53-
Price to Book Ratio2.06-2.06-2.51-1.85-2.35-
Price-to-Total Gains Ratio-16.31--16.31--525.82--70.54--74.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.610844
Number of shares1637
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.06-0.03
Usd Total Gains Per Share-0.05-0.02
Gains per Quarter (1637 shares)-86.28-38.91
Gains per Year (1637 shares)-345.12-155.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
153-398-35572-227-166
2107-797-700143-455-322
3160-1195-1045215-682-478
4213-1594-1390287-909-634
5267-1992-1735358-1137-790
6320-2391-2080430-1364-946
7373-2789-2425502-1591-1102
8427-3188-2770573-1818-1258
9480-3586-3115645-2046-1414
10533-3984-3460717-2273-1570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%14.02.00.087.5%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%10.06.00.062.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.01.093.8%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%12.04.00.075.0%

Fundamentals of Honz

About Hainan Honz Pharmaceutical Co

Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks. It markets its products through a network of agents and sales terminals. The company was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. was founded in 1993 and is headquartered in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-04-16 12:05:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hainan Honz Pharmaceutical Co.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Honz earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Honz to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -35.0% means that ¥-0.35 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is -35.0%. The company is making a huge loss. -2
  • The TTM is -35.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-35.0%TTM-35.0%0.0%
TTM-35.0%YOY1.3%-36.3%
TTM-35.0%5Y-6.8%-28.3%
5Y-6.8%10Y2.3%-9.0%
1.1.2. Return on Assets

Shows how efficient Honz is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Honz to the Drug Manufacturers - Specialty & Generic industry mean.
  • -8.2% Return on Assets means that Honz generated ¥-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is -8.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.2%TTM-8.2%0.0%
TTM-8.2%YOY0.4%-8.6%
TTM-8.2%5Y-1.6%-6.6%
5Y-1.6%10Y0.3%-1.9%
1.1.3. Return on Equity

Shows how efficient Honz is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Honz to the Drug Manufacturers - Specialty & Generic industry mean.
  • -14.3% Return on Equity means Honz generated ¥-0.14 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is -14.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.3%TTM-14.3%0.0%
TTM-14.3%YOY0.7%-15.0%
TTM-14.3%5Y-2.8%-11.5%
5Y-2.8%10Y0.0%-2.7%

1.2. Operating Efficiency of Hainan Honz Pharmaceutical Co.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Honz is operating .

  • Measures how much profit Honz makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Honz to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.6%+0.6%
TTM-5Y2.2%-2.2%
5Y2.2%10Y4.0%-1.9%
1.2.2. Operating Ratio

Measures how efficient Honz is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.72 means that the operating costs are ¥1.72 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is 1.719. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.719. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.719TTM1.7190.000
TTM1.719YOY1.477+0.241
TTM1.7195Y1.518+0.201
5Y1.51810Y1.175+0.343

1.3. Liquidity of Hainan Honz Pharmaceutical Co.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Honz is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.33 means the company has ¥1.33 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is 1.329. The company is just able to pay all its short-term debts.
  • The TTM is 1.329. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.329TTM1.3290.000
TTM1.329YOY1.485-0.156
TTM1.3295Y1.318+0.011
5Y1.31810Y1.560-0.242
1.3.2. Quick Ratio

Measures if Honz is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Honz to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.14 means the company can pay off ¥0.14 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is 0.141. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.141. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.141TTM0.1410.000
TTM0.141YOY0.453-0.312
TTM0.1415Y0.296-0.155
5Y0.29610Y0.992-0.696

1.4. Solvency of Hainan Honz Pharmaceutical Co.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Honz assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Honz to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.41 means that Honz assets are financed with 40.8% credit (debt) and the remaining percentage (100% - 40.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is 0.408. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.408. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.408TTM0.4080.000
TTM0.408YOY0.368+0.040
TTM0.4085Y0.335+0.073
5Y0.33510Y0.218+0.117
1.4.2. Debt to Equity Ratio

Measures if Honz is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Honz to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 70.9% means that company has ¥0.71 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hainan Honz Pharmaceutical Co:

  • The MRQ is 0.709. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.709. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.709TTM0.7090.000
TTM0.709YOY0.602+0.107
TTM0.7095Y0.544+0.165
5Y0.54410Y0.332+0.212

2. Market Valuation of Hainan Honz Pharmaceutical Co

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Honz generates.

  • Above 15 is considered overpriced but always compare Honz to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -14.92 means the investor is paying ¥-14.92 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hainan Honz Pharmaceutical Co:

  • The EOD is -10.603. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.921. Based on the earnings, the company is expensive. -2
  • The TTM is -14.921. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.603MRQ-14.921+4.318
MRQ-14.921TTM-14.9210.000
TTM-14.921YOY355.495-370.416
TTM-14.9215Y144.784-159.706
5Y144.78410Y149.049-4.265
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hainan Honz Pharmaceutical Co:

  • The EOD is -126.066. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -177.406. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -177.406. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-126.066MRQ-177.406+51.339
MRQ-177.406TTM-177.4060.000
TTM-177.406YOY-18.721-158.685
TTM-177.4065Y-50.363-127.043
5Y-50.36310Y64.974-115.337
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Honz is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Hainan Honz Pharmaceutical Co:

  • The EOD is 1.467. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.065. Based on the equity, the company is underpriced. +1
  • The TTM is 2.065. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.467MRQ2.065-0.598
MRQ2.065TTM2.0650.000
TTM2.065YOY2.514-0.449
TTM2.0655Y1.854+0.211
5Y1.85410Y2.355-0.501
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hainan Honz Pharmaceutical Co compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.440-0.4400%-0.107-76%-0.251-43%-0.117-73%
Book Value Per Share--3.0123.0120%3.453-13%3.452-13%3.787-20%
Current Ratio--1.3291.3290%1.485-10%1.318+1%1.560-15%
Debt To Asset Ratio--0.4080.4080%0.368+11%0.335+22%0.218+87%
Debt To Equity Ratio--0.7090.7090%0.602+18%0.544+30%0.332+114%
Dividend Per Share--0.0590.0590%0.090-35%0.079-26%0.070-16%
Eps---0.417-0.4170%0.024-1807%-0.080-81%0.014-3050%
Free Cash Flow Per Share---0.035-0.0350%-0.464+1222%-0.338+864%-0.169+381%
Free Cash Flow To Equity Per Share---0.035-0.0350%-0.707+1917%-0.415+1085%-0.205+486%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.931--------
Intrinsic Value_10Y_min---3.559--------
Intrinsic Value_1Y_max---0.112--------
Intrinsic Value_1Y_min---0.393--------
Intrinsic Value_3Y_max---0.181--------
Intrinsic Value_3Y_min---1.157--------
Intrinsic Value_5Y_max---0.061--------
Intrinsic Value_5Y_min---1.888--------
Market Cap1989000000.000-41%2799000000.0002799000000.0000%3906000000.000-28%2860200000.000-2%4054950000.000-31%
Net Profit Margin---0.350-0.3500%0.013-2766%-0.068-81%0.023-1637%
Operating Margin----0%-0.0060%0.022-100%0.040-100%
Operating Ratio--1.7191.7190%1.477+16%1.518+13%1.175+46%
Pb Ratio1.467-41%2.0652.0650%2.514-18%1.854+11%2.355-12%
Pe Ratio-10.603+29%-14.921-14.9210%355.495-104%144.784-110%149.049-110%
Price Per Share4.420-41%6.2206.2200%8.680-28%6.356-2%9.011-31%
Price To Free Cash Flow Ratio-126.066+29%-177.406-177.4060%-18.721-89%-50.363-72%64.974-373%
Price To Total Gains Ratio-11.590+29%-16.309-16.3090%-525.819+3124%-70.538+332%-74.531+357%
Quick Ratio--0.1410.1410%0.453-69%0.296-52%0.992-86%
Return On Assets---0.082-0.0820%0.004-1934%-0.016-81%0.003-2454%
Return On Equity---0.143-0.1430%0.007-2051%-0.028-81%0.000-100%
Total Gains Per Share---0.381-0.3810%-0.017-96%-0.172-55%-0.047-88%
Usd Book Value--187331290.286187331290.2860%214713305.713-13%214660073.146-13%235494199.842-20%
Usd Book Value Change Per Share---0.061-0.0610%-0.015-76%-0.035-43%-0.016-73%
Usd Book Value Per Share--0.4160.4160%0.477-13%0.477-13%0.523-20%
Usd Dividend Per Share--0.0080.0080%0.012-35%0.011-26%0.010-16%
Usd Eps---0.058-0.0580%0.003-1807%-0.011-81%0.002-3050%
Usd Free Cash Flow---2180438.025-2180438.0250%-28834612.276+1222%-21025334.991+864%-10487593.942+381%
Usd Free Cash Flow Per Share---0.005-0.0050%-0.064+1222%-0.047+864%-0.023+381%
Usd Free Cash Flow To Equity Per Share---0.005-0.0050%-0.098+1917%-0.057+1085%-0.028+486%
Usd Market Cap274879800.000-41%386821800.000386821800.0000%539809200.000-28%395279640.000-2%560394090.000-31%
Usd Price Per Share0.611-41%0.8600.8600%1.200-28%0.878-2%1.245-31%
Usd Profit---25924207.024-25924207.0240%1518473.190-1807%-4985004.331-81%804943.079-3321%
Usd Revenue--74040009.55874040009.5580%115613394.328-36%115677003.154-36%86434131.314-14%
Usd Total Gains Per Share---0.053-0.0530%-0.002-96%-0.024-55%-0.007-88%
 EOD+3 -5MRQTTM+0 -0YOY+10 -245Y+10 -2510Y+10 -25

3.2. Fundamental Score

Let's check the fundamental score of Hainan Honz Pharmaceutical Co based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.603
Price to Book Ratio (EOD)Between0-11.467
Net Profit Margin (MRQ)Greater than0-0.350
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.141
Current Ratio (MRQ)Greater than11.329
Debt to Asset Ratio (MRQ)Less than10.408
Debt to Equity Ratio (MRQ)Less than10.709
Return on Equity (MRQ)Greater than0.15-0.143
Return on Assets (MRQ)Greater than0.05-0.082
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Hainan Honz Pharmaceutical Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.407
Ma 20Greater thanMa 504.943
Ma 50Greater thanMa 1004.864
Ma 100Greater thanMa 2005.437
OpenGreater thanClose4.480
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Retained Earnings  273,325-102,317171,0089,339180,3471,991182,338-240,411-58,074
EBITDA  99,787-43,78256,00541,33697,341-13,59183,750-227,622-143,872
Operating Income  38,795-28,52710,26874,51984,787-69,56315,224-136,626-121,402
Tax Provision  13,124-1,45211,672-2,8988,7741,0099,783-33,348-23,565



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,288,472
Total Liabilities932,963
Total Stockholder Equity1,316,183
 As reported
Total Liabilities 932,963
Total Stockholder Equity+ 1,316,183
Total Assets = 2,288,472

Assets

Total Assets2,288,472
Total Current Assets670,460
Long-term Assets1,618,012
Total Current Assets
Cash And Cash Equivalents 269,812
Net Receivables 71,131
Inventory 170,404
Other Current Assets 769
Total Current Assets  (as reported)670,460
Total Current Assets  (calculated)512,116
+/- 158,344
Long-term Assets
Property Plant Equipment 950,534
Goodwill 18,892
Intangible Assets 204,899
Long-term Assets Other 114,369
Long-term Assets  (as reported)1,618,012
Long-term Assets  (calculated)1,288,694
+/- 329,318

Liabilities & Shareholders' Equity

Total Current Liabilities504,511
Long-term Liabilities428,453
Total Stockholder Equity1,316,183
Total Current Liabilities
Short Long Term Debt 133,218
Accounts payable 57,401
Other Current Liabilities 3,755
Total Current Liabilities  (as reported)504,511
Total Current Liabilities  (calculated)194,374
+/- 310,137
Long-term Liabilities
Long term Debt 342,846
Long-term Liabilities  (as reported)428,453
Long-term Liabilities  (calculated)342,846
+/- 85,607
Total Stockholder Equity
Total Stockholder Equity (as reported)1,316,183
Total Stockholder Equity (calculated)0
+/- 1,316,183
Other
Capital Stock450,000
Common Stock Shares Outstanding 450,000
Net Debt 206,251
Net Invested Capital 1,792,247
Net Working Capital 165,949
Property Plant and Equipment Gross 1,313,813



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
141,572
206,339
294,087
1,904,619
1,967,171
1,969,036
1,904,509
1,927,175
2,089,865
2,189,462
2,235,980
2,180,457
2,194,418
2,613,674
2,458,782
2,288,472
2,288,4722,458,7822,613,6742,194,4182,180,4572,235,9802,189,4622,089,8651,927,1751,904,5091,969,0361,967,1711,904,619294,087206,339141,572
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
1,472,114
1,471,368
687,751
526,029
708,975
719,900
670,460
670,460719,900708,975526,029687,7511,471,3681,472,114000000000
       Cash And Cash Equivalents 
60,228
79,992
100,694
1,449,608
1,092,696
1,142,154
1,039,923
1,043,725
261,024
164,096
118,393
84,170
165,539
258,270
258,553
269,812
269,812258,553258,270165,53984,170118,393164,096261,0241,043,7251,039,9231,142,1541,092,6961,449,608100,69479,99260,228
       Short-term Investments 
0
0
0
0
0
0
0
50,000
952,500
29,355
14,154
0
20,530
0
0
0
00020,530014,15429,355952,50050,0000000000
       Net Receivables 
24,113
21,167
25,910
99,985
185,005
114,299
68,831
98,093
105,875
103,806
204,838
169,110
112,854
145,673
219,453
71,131
71,131219,453145,673112,854169,110204,838103,806105,87598,09368,831114,299185,00599,98525,91021,16724,113
       Other Current Assets 
4,033
6,455
36,602
101,788
60,929
54,045
92,212
27,026
13,803
16,211
32,128
299,142
55,628
59,695
43,587
769
76943,58759,69555,628299,14232,12816,21113,80327,02692,21254,04560,929101,78836,6026,4554,033
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
717,348
822,778
1,492,706
1,668,389
1,904,699
1,738,882
1,618,012
1,618,0121,738,8821,904,6991,668,3891,492,706822,778717,348000000000
       Property Plant Equipment 
33,763
55,689
111,399
215,902
462,562
493,626
497,861
364,626
338,436
326,035
472,140
663,734
681,838
904,229
989,877
950,534
950,534989,877904,229681,838663,734472,140326,035338,436364,626497,861493,626462,562215,902111,39955,68933,763
       Goodwill 
0
0
0
0
0
0
0
32,563
31,062
26,744
26,744
310,428
308,653
308,653
18,892
18,892
18,89218,892308,653308,653310,42826,74426,74431,06232,5630000000
       Intangible Assets 
11,557
29,230
6,031
5,595
76,871
65,529
121,459
277,328
289,653
292,666
281,797
290,691
205,054
195,487
240,515
204,899
204,899240,515195,487205,054290,691281,797292,666289,653277,328121,45965,52976,8715,5956,03129,23011,557
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
29,089
27,886
94,648
145,260
155,135
164,705
114,369
114,369164,705155,135145,26094,64827,88629,089000000000
> Total Liabilities 
25,683
55,925
53,596
76,013
106,972
86,231
94,363
98,429
248,247
316,826
315,309
526,896
592,595
1,011,926
905,140
932,963
932,963905,1401,011,926592,595526,896315,309316,826248,24798,42994,36386,231106,97276,01353,59655,92525,683
   > Total Current Liabilities 
25,683
55,925
53,196
70,109
102,639
82,398
88,864
86,855
214,596
275,775
400,463
463,417
490,462
580,776
484,920
504,511
504,511484,920580,776490,462463,417400,463275,775214,59686,85588,86482,398102,63970,10953,19655,92525,683
       Short-term Debt 
0
0
0
0
0
0
0
0
0
100,000
100,000
190,000
0
0
0
0
0000190,000100,000100,000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
100,000
100,000
190,000
209,625
297,575
148,500
133,218
133,218148,500297,575209,625190,000100,000100,000000000000
       Accounts payable 
10,511
22,747
15,869
25,671
38,183
23,756
23,060
24,570
54,594
54,981
99,817
80,977
123,136
110,361
112,328
57,401
57,401112,328110,361123,13680,97799,81754,98154,59424,57023,06023,75638,18325,67115,86922,74710,511
       Other Current Liabilities 
9,172
24,678
28,827
44,438
39,988
58,642
65,804
61,536
80,002
96,627
140,922
162,061
136,777
142,165
92,843
3,755
3,75592,843142,165136,777162,061140,92296,62780,00261,53665,80458,64239,98844,43828,82724,6789,172
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
41,051
49,393
63,479
102,133
431,150
420,219
428,453
428,453420,219431,150102,13363,47949,39341,051000000000
       Other Liabilities 
0
0
400
5,904
4,333
3,833
5,433
11,508
11,793
41,051
50,810
50,479
72,908
106,652
76,702
0
076,702106,65272,90850,47950,81041,05111,79311,5085,4333,8334,3335,90440000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
28,186
49,208
54,405
60,623
72,732
72,858
0
072,85872,73260,62354,40549,20828,186000000000
> Total Stockholder Equity
115,889
150,414
240,491
1,828,606
1,771,422
1,794,759
1,727,036
1,746,118
1,762,119
1,800,617
1,850,814
1,544,187
1,498,480
1,502,457
1,503,949
1,316,183
1,316,1831,503,9491,502,4571,498,4801,544,1871,850,8141,800,6171,762,1191,746,1181,727,0361,794,7591,771,4221,828,606240,491150,414115,889
   Common Stock
75,000
75,000
75,000
100,000
200,000
200,000
200,000
300,000
450,000
450,000
450,000
450,000
450,000
450,000
450,000
0
0450,000450,000450,000450,000450,000450,000450,000300,000200,000200,000200,000100,00075,00075,00075,000
   Retained Earnings 
284
29,856
112,627
240,919
182,885
203,531
132,202
179,613
195,614
241,657
259,959
273,325
171,008
180,347
182,338
-58,074
-58,074182,338180,347171,008273,325259,959241,657195,614179,613132,202203,531182,885240,919112,62729,856284
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
51,798
52,174
52,651
0
052,65152,17451,798000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue638,298
Cost of Revenue-279,328
Gross Profit358,970358,970
 
Operating Income (+$)
Gross Profit358,970
Operating Expense-670,241
Operating Income-31,943-311,271
 
Operating Expense (+$)
Research Development30,959
Selling General Administrative280,244
Selling And Marketing Expenses-
Operating Expense670,241311,202
 
Net Interest Income (+$)
Interest Income3,060
Interest Expense-25,111
Other Finance Cost-1,501
Net Interest Income-23,553
 
Pretax Income (+$)
Operating Income-31,943
Net Interest Income-23,553
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-120,862-31,943
EBIT - interestExpense = -25,111
-98,428
-73,317
Interest Expense25,111
Earnings Before Interest and Taxes (EBIT)--95,751
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-120,862
Tax Provision--12,272
Net Income From Continuing Ops-108,591-108,591
Net Income-98,428
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-23,553
 

Technical Analysis of Honz
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Honz. The general trend of Honz is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Honz's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hainan Honz Pharmaceutical Co.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.6 < 4.85 < 5.27.

The bearish price targets are: 3.75.

Tweet this
Hainan Honz Pharmaceutical Co Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hainan Honz Pharmaceutical Co. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hainan Honz Pharmaceutical Co Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hainan Honz Pharmaceutical Co. The current macd is -0.1480444.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Honz price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Honz. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Honz price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hainan Honz Pharmaceutical Co Daily Moving Average Convergence/Divergence (MACD) ChartHainan Honz Pharmaceutical Co Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hainan Honz Pharmaceutical Co. The current adx is 21.71.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Honz shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Hainan Honz Pharmaceutical Co Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hainan Honz Pharmaceutical Co. The current sar is 5.03987112.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hainan Honz Pharmaceutical Co Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hainan Honz Pharmaceutical Co. The current rsi is 37.41. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Hainan Honz Pharmaceutical Co Daily Relative Strength Index (RSI) ChartHainan Honz Pharmaceutical Co Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hainan Honz Pharmaceutical Co. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Honz price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Hainan Honz Pharmaceutical Co Daily Stochastic Oscillator ChartHainan Honz Pharmaceutical Co Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hainan Honz Pharmaceutical Co. The current cci is -163.43234323.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Hainan Honz Pharmaceutical Co Daily Commodity Channel Index (CCI) ChartHainan Honz Pharmaceutical Co Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hainan Honz Pharmaceutical Co. The current cmo is -30.72208313.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hainan Honz Pharmaceutical Co Daily Chande Momentum Oscillator (CMO) ChartHainan Honz Pharmaceutical Co Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hainan Honz Pharmaceutical Co. The current willr is -76.57657658.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Honz is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hainan Honz Pharmaceutical Co Daily Williams %R ChartHainan Honz Pharmaceutical Co Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hainan Honz Pharmaceutical Co.

Hainan Honz Pharmaceutical Co Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hainan Honz Pharmaceutical Co. The current atr is 0.20703606.

Hainan Honz Pharmaceutical Co Daily Average True Range (ATR) ChartHainan Honz Pharmaceutical Co Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hainan Honz Pharmaceutical Co. The current obv is 266,434,111.

Hainan Honz Pharmaceutical Co Daily On-Balance Volume (OBV) ChartHainan Honz Pharmaceutical Co Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hainan Honz Pharmaceutical Co. The current mfi is 42.83.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hainan Honz Pharmaceutical Co Daily Money Flow Index (MFI) ChartHainan Honz Pharmaceutical Co Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hainan Honz Pharmaceutical Co.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Hainan Honz Pharmaceutical Co Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hainan Honz Pharmaceutical Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.407
Ma 20Greater thanMa 504.943
Ma 50Greater thanMa 1004.864
Ma 100Greater thanMa 2005.437
OpenGreater thanClose4.480
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Honz with someone you think should read this too:
  • Are you bullish or bearish on Honz? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Honz? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hainan Honz Pharmaceutical Co

I send you an email if I find something interesting about Hainan Honz Pharmaceutical Co.


Comments

How you think about this?

Leave a comment

Stay informed about Hainan Honz Pharmaceutical Co.

Receive notifications about Hainan Honz Pharmaceutical Co in your mailbox!